Organigram (NASDAQ:OGI) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Organigram (NASDAQ:OGI) announced its quarterly earnings data on Tuesday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.02), Zacks reports. Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Organigram Stock Down 16.8 %

Shares of OGI stock opened at $1.44 on Wednesday. Organigram has a one year low of $1.31 and a one year high of $2.91. The company has a 50 day moving average price of $1.57 and a 200 day moving average price of $1.67.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.